Introduction
Descending thoracic aorta (DTA) disease remains a formidable challenge, as the conventional therapy in this era continues to carry significant morbidity and mortality which become even more significant for thoracic aortic emergencies w1x. In addition, the high frequency of comorbidities accompanying this patient population often make them unsuitable candidates for open surgery. The advent and applicability of endovascular stent grafts for treating lesions involving the DTA seems to offer a less invasive alternative, having the potential to reduce the mortality and morbidity as well as expand the number of patients to whom intervention can safely be performed. In many studies so far, endovascular repair of thoracic aorta (TEVAR) appears to be associated with decreased perioperative mortality rates and complications w2x. However, data on long-term follow-up are still limited. . E-mail address: mimats@cc.uoi.gr, mmats@otenet.gr (M.I. Matsagkas).
The aim of this study was to review the six-year results with TEVAR in our center, reporting the operative results, the early perioperative outcomes as well as the mid-term follow-up of the treated patients.
Materials and methods
We retrospectively reviewed 55 consecutive patients who underwent endovascular repair for thoracic aortic pathology between 2004 and 2009 at our institution. The mean age of the patients was 63 years (S.D."16, median: 66, range: 17-83 years), while 52 (94.5%) were male. All patients gave informed consent to undergo endovascular stent graft repair and the procedures were performed from the same surgical and anesthesiological team. Preoperative evaluation for all patients consisted of computed tomography (CT) angiography of the chest, abdomen and pelvis with multiplanar reconstruction when necessary. Follow-up with clinical examination and CT-scan was routinely performed at one, six and 12 months and annually thereafter. Patients' characteristics are presented in Table 1 . Fortyseven patients (85.5%) were assessed to have an American Society of Anesthesiologists (ASA) clinical status of 3 or 4. The pathology of all 55 patients is presented in Table 2 . Our indications to perform TEVAR were any complicated aneurysm or one with a diameter )5 cm, any complicated acute aortic syndrome, or any traumatic rapture, if the aortic anatomy was suitable. The criteria used to determine the anatomical suitability for TEVAR were a proximal and distal landing zone length of about 2 cm. However, in eight cases (14.5%) there was an inadequate neck for proximal fixation and we proceeded to left subclavian artery (LSA) overstenting. All endografts were oversized, by approximately, 10-20% according to manufacturer recommendations. All of the cases were performed under general anesthesia except one, which was performed under spinal anesthesia. All the endografts but one, were deployed through a common femoral artery access. In one patient we used the external iliac artery due to the inadequate diameter of the common femoral artery. Additionally, the left radial artery was catheterized and a 5-F sheath was inserted in all cases. An angiography catheter was then forwarded into the aortic arch to perform intraoperative angiography. With the placement of the angiography catheter in the LSA and the aortic arch we always had a continuous marker of the orifice of the LSA during the graft deployment. We used cerebrospinal fluid (CSF) drainage in only one patient, in whom we proceeded to extensive coverage of the DTA and to overstenting of the LSA. In two more patients with the same problem we were not able to use CSF drainage because they were in antiplatelet therapy which had to be continued. In this cohort of patients, nine of them had a history of an abdominal aortic aneurysm (AAA), while one had dissection of the abdominal aorta. In seven cases we proceed to concomitant repair of the thoracic and abdominal aorta lesion, while three patients had their AAA previously repaired by open surgery. In one case, the endovascular procedure was performed as the second-stage procedure for the repair of the DTA aneurysm after previous aortic valve, ascending aorta, and aortic arch replacement with the elephant trunk technique w3x. In this case, the proximal landing zone of the endograft was into the previously placed synthetic Dacron graft, just proximal to the distal arch anastomosis. At the end of the procedure all patients except two were transferred to intensive care unit (ICU), for the early postoperative period.
Perioperative and follow-up data were collected prospectively for all patients and stored in a data base. Primary technical success of the procedure was defined as complete exclusion of the aneurysm sac, seal of rupture, or coverage of the entry tear for dissections with absence of any type I or III endoleak after the end of the procedure.
Patients survival was estimated using Kaplan-Meier analysis, taking time zero as the date of operation and late death as the end point. The correlation between mortality and emergency operation, as well mortality and age was examined using x -test, or Fisher exact test when appro-2 priate, with P considered as significant when -0.05. Data were analysed using the SPSS software package v. 15.0 (SPSS, Inc, Chicago, IL, USA).
Results
Thirty patients (54.5%) were treated electively and 25 (45.5%) in an emergency. Operative data are shown in Table  3 . In this series the primary technical success was 92.7% (51y55). In 41 patients we used the Talent or Valiant devices (Medtronic AVE, Medtronic Europe SA, Route du Molliau, Switzerland), in nine cases we used the TAG device (W.L. Gore & Associates, Inc, Flagstaff, AZ, USA), while in four cases we used the Relay device (Bolton Medical, Inc, Sunrise, FL, USA). In 27 patients we used more than one endograft in order to exclude the lesion. Patients' outcome and complications are shown in Table 4 . In one case, with a ruptured degenerative aneurysm, there was an inability to advance the device and cover the rupture due to severe rachioscoliosis and huge multiple angulations of the thoracoabdominal aorta. In another patient we failed to exclude completely the distal sac of the aneurysm, however, the patient was treated successfully two months later with the deployment of an extra graft. We also encountered two type III endoleaks during the initial procedure, which spontaneously disappeared on the second day and first month postoperatively, respectively. We also observed a type II endoleak one month after the procedure. This was a ruptured false anastomotic aneurysm w3x, and the endoleak was attributed to prior erosion of the lung from the aneurysm. In this case the endoleak sealed spontaneously in the 18th postoperative month. No early or late open conversions were necessary and no graft migration has so far been noted. Operation-related complications occurred in seven patients (12.7%). In two cases we faced artery access complications attributed to bulky devises. In one female patient, suffering from aortic traumatic rapture, there was disruption of the external iliac artery during the withdrawal of a 24-F device, and we had to proceed to immediate revascularization with external-external iliac artery bypass using a polytetrafluoroethylene interposition graft. In another patient suffering from a ruptured DTA aneurysm, we proceeded to over-dilatation of a previously deployed iliac artery stent in order to pass the 24-F device, but an occlusion of the only patent and heavily stenotic internal iliac artery occurred. The patient developed extensive buttock necrosis as well as delayed paraparesis and eventually died from myocardial infarction on the 30th postoperative day (POD).
Early postoperative complications occurred in five patients and included myocardial infarction (ns3), acute respiratory distress syndrome (ns1) and delayed parapareses (ns2). In the latter two cases the neurological deficit developed at the third POD resulting in an overall incidence of neurological complications of 3.6% (2y55). Eight patients in this study (14.5%) did not have an adequate landing zone for the proximal fixation of the graft and we intentionally covered the orifice of the LSA; however, none of these patients developed clinical evidence of left upper extremity claudication, retrograde endoleak via the LSA or any neurological complication. The median length of ICU and hospital stay was one day (0-30 days) and five days (3-45 days), respectively. The mean whole blood transfusion was one unit (S.D."1), while one patient required platelet transfusion because of a severe postoperative decrease in the platelet count (-50=10 yml). The combined 30-day 3 and in-hospital mortality in this series was 9.1% (5y55). The causes of death included the one technical failure to cover the rupture of a degenerative aneurysm mentioned above where the patient died intraoperatively, one acute respiratory distress syndrome and three myocardial infarctions. Deaths within the first 30 days occurred exclusively in patients treated in an emergency situation (Fisher exact test, Ps0.01).
The mean follow-up period was 34 months (S.D."22.5, median: 34.5, range: 1-80 months) while three patients were lost from follow-up at 24, 36 and 48 months. Late deaths ()30 days) were observed in six of our patients. Five of them died from myocardial infarction at the ninth, 12th, 41th, 50th and 65th month, respectively, while one died from a new acute type A dissection at the sixth month. The overall cumulative survival at four years was estimated at 72.6% (S.E. 9.2%, Fig. 1 ). During the follow-up period of the 32 patients with aneurysms, the aneurysm sac has begun to shrink in 13 of them, while in two the sac has almost disappeared (overall 46.9% shrinkage rate), whereas in the remaining cases, the sac volume was stable. In 15 out of 17 (88%) patients with acute dissections or a penetrating ulcer, total or partial remodeling of the DTA has been noticed so far.
Discussion
Along with the aging of the population, there is an increase in the medical comorbidities accompanying patients with lesions involving the DTA, often precluding them from a safe open procedure, which is in any case a major operation with a high risk of complications w1x. Therefore, a minimally-invasive approach with acceptable mortality and morbidity rates seemed to be demanded. In 1994, the Stanford group reported their initial experience in the treatment of descending thoracic aortic lesions with self-expanding stent grafts w4x, proposing that this new technology could have favorable results in the treatment of a wide variety of lesions. Since then, many reports in the literature have demonstrated favorable outcomes for TEVAR applied either electively or emergently, with highly technical success rates and comparatively low mortality w5x. The avoidance of thoracotomy, aortic cross-clamping, left-sided heart bypass, the limited blood loss and the short procedural time seems to contribute well to these results. The Eurostar Thoracic Endograft registry reported a 30-day mortality of 9.3% in a series of 443 patients treated with TEVAR w6x. Other large series report slightly lower rates, between 0% and 6% w7-9x, while in our population the 30-day mortality was 9.1% (5y55). It is worthwhile to mention that all five patients underwent TEVAR emergently, so the early mortality in this group of patients reached 20% (5y 25). Eurostar registry reported a similar 30-day mortality rate (18.3%) in the emergently treated patients, while in the elective procedures it reached 4.9% w6x. Similar to others w10x, in this cohort no one died among the electively treated patients. Thus, almost 10 years after the wide application of TEVAR in various DTA pathologies it is nowadays quite evident that endovascular treatment reduces the risk of all-cause mortality at 30 days in comparison to open surgery and this was recently documented in a metaanalysis of 42 comparative studies involving 5888 patients w11x.
Apart from mortality, morbidity is another crucial factor that determines the acceptance of thoracic stent endografting. TEVAR studies in the literature report favorable morbidity rates as regards major complications like paraplegia, myocardial infarction, stroke, respiratory and renal insufficiency w5, 11-14x. Among them paraplegia is a dreaded and devastating complication, which after open thoracic aortic surgery ranges from 2 to 21% w1, 15x. Endovascular repair has been reported to reduce the incidence of spinal cord ischemia (SCI) by between 0% and 6% w6, 8, 16x. The Eurostar registry reported 4% paraplegia for patients with degenerative aneurysms and 0.8% for those with aortic dissections w 6x. The length of aortic coverage and especially the coverage of the 'crucial zone' T9-L1 has been correlated with increased paraplegia rates w2, 16-18x. However, there are reports without neurological complications even though many patients had the critical lower thoracic segment completely covered with the stent graft w5, 19x. In the present study 13 of the patients had the area below the T9 segment covered and only one of them developed delayed paraparesis. In our opinion more factors than the covered aortic length may determine the risk of SCI. Many studies so far associated SCI with concomitant or previous AAA repair w19, 20x. Mitchell et al. w21x reported four patients (3.7%) with paraplegia in the Stanford TEVAR series of 108 patients and three of whom had a history of AAA repair. In a recent study the incidence of SCI in patients with either repaired or unrepaired AAA was 18% (18y101) vs. 6% (9y160) in patients without any history of AAA w20x. The authors conclude that patients with a history of AAA face over four times the increased risk of developing SCI and this is independent of the length of thoracic aorta covered. In our study nine patients had a history of AAA and one patient had a dissection in the abdominal aorta. In seven cases we proceeded to concomitant repair of the thoracic and abdominal aorta lesion, while three patients had their AAA previously repaired by open surgery. None of these patients developed neurological deficit although many intercostal and lumbar arteries had been excluded w22x. In two of these cases the distal seal of the thoracic endograft exceeded the ninth thoracic vertebra. Perioperative hypotension has been postulated as an inciting factor in delayed onset of SCI w16, 19x. In this study two patients (3.9%) developed delayed paraparesis at the third POD. The first patient underwent TEVAR for ruptured TAA, while the over dilatation of a previous iliac stent resulted in the occlusion of the only patent hypogastric artery. We speculate that the perioperative hypovolemic status of this patient along with the occlusion of the hypogastric artery, might have contributed to the development of the SCI. The other patient underwent elective TEVAR for TAA. The latter was a patient of advanced age in whom an extensive coverage of the DTA was needed in order to exclude the lesion. In this patient the advanced age along with the extensive coverage of the DTA might have resulted in delayed paraparesis. The above-mentioned results are in favor of the opinion that the development of SCI after TEVAR is a complex interaction of different mechanisms in each particular patient.
The stent coverage of the LSA orifice is commonly used in cases where there is no adequate neck (20 mm) for proximal fixation. Prior publications have associated LSA overstenting with SCI w18x. In the Eurostar study LSA occlusion has been associated with an almost four-fold increased incidence of paraplegia w18x, but others have not found such a correlation w20, 23x. In this series eight patients (14.5%) had the LSA covered and none of them developed SCI symptoms. In our opinion, the actual contribution of one vertebral artery via the anterior spinal artery to the overall spinal perfusion is difficult to determine the development of SCI symptoms. Thus prophylactic revascularization in every case of LSA over-stenting is not justified. Apart from SCI, there are also concern about the development of left upper extremity ischemia, posterior cerebral stroke and vertebral artery steal syndrome. This concern led some surgeons to perform a prophylactic revascularization procedure in patients with LSA coverage w18x. However, many studies suggest that stent coverage of LSA is well tolerated and rarely requires secondary intervention with arm revascularization w24, 25x. In our study none of the eight patients had clinical evidence of left upper extremity claudication, retrograde endoleak via the LSA or stroke. We follow the policy of proceeding to LSA overstenting when it is indicated, and only when there is clinical evidence of a complication do we perform a revascularization procedure. However, prior to intentional occlusion of LSA, attention has to be paid to potential supra-aortic variants and pathologies during pre-interventional imaging.
As with previously reported single institution studies, our results are limited by the small number of patients and the mid-term follow-up period. Although long-term reliability of stent grafts is still under question, this minimallyinvasive technique seems to be a well-established alternative for the management of DTA disease, with favorable morbidity and mortality rates. Taking into account the so far promising results and the potential of a wide application of TEVAR in many vascular centers, stenting of the thoracic aorta might offer an overall better solution for the patients suffering from these devastating pathologies.
